Literature DB >> 24406042

Ran GTPase induces EMT and enhances invasion in non-small cell lung cancer cells through activation of PI3K-AKT pathway.

Jinfeng Ning1, Wei Liu, Jinfeng Zhang, Yaoguo Lang, Shidong Xu.   

Abstract

Ras-related nuclear protein (Ran) GTPase is upregulated in non-small cell lung cancer (NSCLC) cells and is required for NSCLC cell survival. However, the effect of Ran on NSCLC cell invasion and epithelial to mesenchymal transition (EMT) remains unclear. This study found that Ran expression was much higher in highly invasive NSCLC cells than in lowly invasive NSCLC cells. Ectopic expression of Ran enhanced invasion and induced EMT in NSCLC cells. Inhibition of the PI3K-AKT pathway by LY294002, but not the MEK-ERK pathway by PD98509, reversed the above effects in these cells induced by Ran overexpression. In conclusion, our findings demonstrate that Ran induces EMT and enhances invasion in NSCLC cells through the activation of PI3K-AKT signaling. Thus, Ran may be a potential target for NSCLC therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24406042     DOI: 10.3727/096504013X13747716581417

Source DB:  PubMed          Journal:  Oncol Res        ISSN: 0965-0407            Impact factor:   5.574


  15 in total

1.  Epithelial-mesenchymal transition: a new target in anticancer drug discovery.

Authors:  Fabrizio Marcucci; Giorgio Stassi; Ruggero De Maria
Journal:  Nat Rev Drug Discov       Date:  2016-01-29       Impact factor: 84.694

2.  High expression of Ran binding protein 1 predicts poor outcomes in hepatocellular carcinoma patients: a Cancer Genome Atlas database analysis.

Authors:  Zhengxiao Wei; Xiaoqiong Duan; Qi Li; Qingfeng Li; Yu Wang
Journal:  J Gastrointest Oncol       Date:  2021-12

3.  Quantitative proteomic profiling of paired cancerous and normal colon epithelial cells isolated freshly from colorectal cancer patients.

Authors:  Chengjian Tu; Wilfrido Mojica; Robert M Straubinger; Jun Li; Shichen Shen; Miao Qu; Lei Nie; Rick Roberts; Bo An; Jun Qu
Journal:  Proteomics Clin Appl       Date:  2017-01-20       Impact factor: 3.494

4.  Decreased miR-204 in H. pylori-associated gastric cancer promotes cancer cell proliferation and invasion by targeting SOX4.

Authors:  Xiaoying Zhou; Lin Li; Jing Su; Guoxin Zhang
Journal:  PLoS One       Date:  2014-07-01       Impact factor: 3.240

5.  miR-101 targeting ZFX suppresses tumor proliferation and metastasis by regulating the MAPK/Erk and Smad pathways in gallbladder carcinoma.

Authors:  Run-Fa Bao; Yi-Jun Shu; Yun-Ping Hu; Xu-An Wang; Fei Zhang; Hai-Bin Liang; Yuan-Yuan Ye; Huai-Feng Li; Shan-Shan Xiang; Hao Weng; Yang Cao; Xiang-Song Wu; Mao-Lan Li; Wen-Guang Wu; Yi-Jian Zhang; Lin Jiang; Qian Dong; Ying-Bin Liu
Journal:  Oncotarget       Date:  2016-04-19

6.  From Proteomic Analysis to Potential Therapeutic Targets: Functional Profile of Two Lung Cancer Cell Lines, A549 and SW900, Widely Studied in Pre-Clinical Research.

Authors:  Luís Korrodi-Gregório; Vanessa Soto-Cerrato; Rui Vitorino; Margarida Fardilha; Ricardo Pérez-Tomás
Journal:  PLoS One       Date:  2016-11-04       Impact factor: 3.240

Review 7.  Ran GTPase: A Key Player in Tumor Progression and Metastasis.

Authors:  Zied Boudhraa; Euridice Carmona; Diane Provencher; Anne-Marie Mes-Masson
Journal:  Front Cell Dev Biol       Date:  2020-05-26

8.  Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.

Authors:  Rui Du; Shanshan Wu; Xiaoning Lv; Henghu Fang; Sudong Wu; Jingbo Kang
Journal:  J Exp Clin Cancer Res       Date:  2014-12-14

9.  Proteolytic and non-proteolytic regulation of collective cell invasion: tuning by ECM density and organization.

Authors:  Sandeep Kumar; Aastha Kapoor; Sejal Desai; Mandar M Inamdar; Shamik Sen
Journal:  Sci Rep       Date:  2016-02-02       Impact factor: 4.379

10.  Knockdown of Ran GTPase expression inhibits the proliferation and migration of breast cancer cells.

Authors:  Chenyi Sheng; Jian Qiu; Yingying Wang; Zhixian He; Hua Wang; Qingqing Wang; Yeqing Huang; Lianxin Zhu; Feng Shi; Yingying Chen; Shiyao Xiong; Zhen Xu; Qichao Ni
Journal:  Mol Med Rep       Date:  2018-05-03       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.